New-onset heart failure in association with severe hypertension during trastuzumab therapy

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Heart failure is a dreaded complication of trastuzumab therapy in women with breast cancer overexpressing the human epidermal growth factor receptor (HER)-2. Experimental studies have pointed out that the HER-2 signaling pathway is important in the adaptation to high afterload conditions and its inactivation leads to cardiac decompensation. Herein, we report on 2 patients with breast cancer who were receiving trastuzumab monotherapy and required hospital admission for new-onset heart failure. This occurred at a time of unprecedented blood pressure elevations, in one case due to cessation of antihypertensive medications and in the other case due to a scleroderma crisis. Although trastuzumab may not have been the precipitating factor for blood pressure dyscontrol in these patients, severe, uncontrolled hypertension may have been the precipitating factor for trastuzumab-related acute heart failure. These 2 cases add to previous reports recognizing systemic hypertension as a risk factor for the development of trastuzumab cardiotoxicity and translate experimental observations of the significance of the HER-2 signaling pathway to the bedside. Pending further confirmation, the present observations may raise awareness of the need for appropriate monitoring and control of systemic hypertension in patients receiving trastuzumab, or potentially any other HER-2-targeted therapy.

Original languageEnglish (US)
Pages (from-to)1734-1739
Number of pages6
JournalMayo Clinic proceedings
Volume89
Issue number12
DOIs
StatePublished - Dec 1 2014

Keywords

  • Abbreviations and Acronyms
  • ECG electrocardiogram
  • ED emergency department
  • EF ejection faction
  • ER estrogen receptor
  • ErbB gene symbol for the epidermal growth factor receptor
  • HER human epidermal growth factor receptor
  • PR progesterone receptor

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'New-onset heart failure in association with severe hypertension during trastuzumab therapy'. Together they form a unique fingerprint.

  • Cite this